Based on the aggregated intelligence of 130,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, industrial products maker Illinois Tool Works (NYSE:ITW) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Illinois Tool's business and see what CAPS investors are saying about the stock right now.

Illinois Tool facts 

Headquarters (founded)

Glenview, Ill. (1912)

Market Cap

$14.35 billion


Industrial machinery

Trailing-12-Month Revenue

$15.87 billion


CEO David Speer (since 2005)
CFO Ronald Kropp (since 2006)

Return on Equity (average, last three years)


Dividend Yield



Dover (NYSE:DOV)

CAPS members bullish on ITW also bullish on

General Electric (NYSE:GE)
Procter & Gamble (NYSE:PG)

CAPS members bearish on ITW also bearish on

Mosaic (NYSE:MOS)
Biogen Idec (NASDAQ:BIIB)

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS.

Over on CAPS, fully 568 of the 583 members who have rated Illinois Tool -- some 97% -- believe the stock will outperform the S&P 500 going forward. These bulls include Quicksilver121 and All-Star VALUEDIV, who is ranked in the top 10% of our community.

Two days ago, Quicksilver121 tapped Illinois Tool as a superbly run situation:

[Illinois Tool] is a large company that allows their business units to manage their future. [Illinois Tool] supports the units with guidance (80/20 philosophy) and capital, not bureaucracy. This allows their units to stay focused on what they need to do to grow their business.

In a response to the above pitch, VALUEDIV elaborates on the stock as a proven winner with plenty of potential:

[Illinois Tool] is a very strong fundamental stock that I have watched for 15 years. Unless they become more "acquisition" or "diversification" conscious, they will remain a great solid, but staid investment. … They can stay the course through these rough times and may benefit from the current fix-up and build-up economic trend.

What do you think about Illinois Tool Works, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 130,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. 3M is a Motley Fool Inside Value selection, and Biogen Idec is a selection of Stock Advisor. The Fool owns shares of Procter & Gamble. The Fool's disclosure policy always gets a perfect score.